Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck
β Scribed by Xiao-Ying Yin; Martin L. Smith; Theresa L. Whiteside; Joseph Locker; Jonas T. Johnson; Ronald B. Herberman
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 943 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abnormalities in the p53 gene were studied in a series of cell lines of human squamous-cell carcinoma of the head and neck (SCCHN) and in tumor tissues. Restriction-fragment-length polymorphism (RFLP), quantitative hybridization and immunochemical analysis of mutant p53 proteins were combined to detect and characterize 3 different phases in the p53 gene alteration: mutation (in 9/9 cases), I7p I 3 deletion (9/ 10 cases) and amplification of the non-deleted allele (9/31 cases). In SCCHN, deletion of the p53 gene was nearly always accompanied by mutation, only one cell line studied having mutation without deletion. Alterations in the p53 gene are common in SCCHN, and involve a series of genetic events which occur in sequence during tumor progression.
π SIMILAR VOLUMES
Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (HNSCCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this
The presence of gene amplification was determined in 66 fresh head-and-neck SCC specimens using a battery of 9 different probes. Amplification of at least one gene was found in I 2 samples (18%), of which 7 were amplified at multiple loci (58%). We observed amplifications for EGFR (10% of samples) a
## Abstract ## Background. Although cyclooxygenaseβ2 (COXβ2) has been suggested to play an important role in carcinogenesis, the effects of tumor suppressors on COXβ2 gene expression and the combined antitumor effects of tumor suppressors and COXβ2 inhibitors have rarely been investigated. ## Met
## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did